CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, is proud to announce the launch of its new line of user-friendly Tissue Clearing Kits and Reagents. These innovative products are designed to help researchers achieve more detailed imaging of tissue samples, thereby advancing the field of biomedical research. Tissue clearance techniques allow detailed imaging of intact tissue samples. By eliminating the light-scattering properties of tissues,...

CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, is proud to announce the launch of its new Multicolor Immunofluorescence Staining Kits. These kits empower researchers to achieve high-quality staining of tissues and cells utilizing 2-7 different colors, enabling more detailed and comprehensive analysis. By providing researchers with the tools they need to achieve exceptional multicolor staining, CD BioSciences is committed to supporting gro...

CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, proudly announces an extensive portfolio of Nervous System Tissue Microarrays designed to support neuroscience research. This comprehensive collection provides researchers with a unique resource to study various neurological conditions and accelerate their investigations into neurological diseases and disorders. CD Bioscience has been developing imaging technologies for many years and uses hi...

CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, is delighted to announce the addition of a new line of IHC Ancillaries to its product portfolio, including deparaffinators, retrievers and enzymes, washers and detergents, diluents and blockers, and mounting media. These ancillaries are developed to facilitate IHC research and diagnostics, enabling scientists, pathologists, and clinicians to achieve more accurate and reliable results. Immunoh...

CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, has announced the launch of its innovative line of Chromogenic Substrates for immunohistochemistry (IHC). These cutting-edge substrates offer superior signal sensitivity, long-term storage stability, enhanced safety, and user-friendliness, empowering researchers to unlock deeper insights into protein expression and function within tissues. Immunohistochemistry is the study of the localization, ...

CD BioSciences, a US-based CRO serving the global life science research community, has announced the launch of its new services to study the Mechanistic Target of Rapamycin (mTOR) in diabetes and metabolism research. The mechanistic Target of Rapamycin is a serine/threonine protein kinase that is inhibited by rapamycin, a bacterial compound originally isolated from Easter Island soil that inhibits the proliferation of eukaryotic cells. The mTOR protein kinase is present in two distinct comple...

CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, has announced the launch of its 3D Image Analysis Services for researchers, from data processing and analysis to custom report generation. Pathogenesis, prevention and treatment of many diseases require pathological studies. Microscopic image analysis of tissues is the basis for a wide range of pathology studies, which require the collection of a small number of tissue samples from a patient. A...

CD BioSciences, a US-based CRO serving the global life science research community, has announced the launch of its new services to study Anabolism in diabetes. The new solutions can help researchers to better understand the the synthesis of molecules. Metabolism is a series of chemical reactions that occur in living systems. The purpose of metabolism is to convert nutrients into energy and building blocks and to eliminate nitrogenous waste. It can be divided into two categories: catabolism (t...

CD BioSciences, a US-based CRO serving the global life science research community, has announced the launch of its new Catabolism research services, which offer researchers a comprehensive range of tools and resources to investigate the role of catabolism in the development and progression of diabetes. Metabolism describes a series of life-sustaining chemical reactions in an organism that convert nutrients into energy and building blocks and eliminate nitrogenous waste. It can be divided into...